Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma.

Clin Cancer Res · 2022 · PMC9365363 · PMID 35165100

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

moderately significantno p-value reported

Two moderately significant NetPath derived signatures corresponding to EGFR and Notch signaling were also found (Supplementary Fig.

also in 2,174 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.